24/03/2026
🧠 EAU 2026: What’s New in Testicular Cancer Care?
📍 Practice-changing updates for early detection, risk-adapted therapy, and survivorship
🔹 1. Early Detection & Imaging
🔍 Scrotal ultrasound remains first-line
🧬 Tumor markers (AFP, β-hCG, LDH) now paired with risk-adapted imaging
→ Reduces delays and improves staging accuracy
🔹 2. Risk-Based Orchiectomy Planning
🔪 Clearer guidance on timing and contralateral te**is evaluation
→ Fertility preservation and hormonal assessment now embedded in pre-op work-up
🔹 3. Surveillance Protocols Refined
📅 Follow-up intervals now stratified by histology and stage
→ Reduces over-imaging and improves compliance
🔹 4. Systemic Therapy Sequencing Updated
💊 BEP vs EP regimens clarified for seminoma vs non-seminoma
→ Toxicity and fertility impact now factored into regimen choice
🔹 5. Survivorship & Late Effects
❤️ Long-term cardiac, metabolic, and fertility risks now addressed
→ Survivorship care plans recommended for all cured patients
📌 What Changes in Practice?
✅ personalize imaging and tumor marker use
✅ embed fertility and hormonal planning pre-op
✅ tailor systemic therapy to histology and risk
✅ follow-up smarter and support survivorship
Dr Bivek Kumar - Urologist